Paul Yook Novus Therapeutics, Inc

As of May 2, 2019


Paul Yook Net Worth

  • Net worth is estimated to be at least $2.88M
  • Owns at least 1,065,867 units of Novus Therapeutics, Inc stock
  • Sold an estimated value of $540 recently at Novus Therapeutics, Inc

Paul Yook Trading

  • Largest sale of shares was 200 units , worth over $540 on May 2, 2019
  • In total has made about 1 transaction recently
  • Usually trades in May, with the busiest year in 2019

LIFESCI INDEX PARTNERS LLC, PAUL YOOK

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Paul Yook Mailing Address

  • Mailing address is Lifesci Index Partners, Llc 250 West 55th Street, Floor 16 New York NY 10019 NY

Novus Therapeutics, Inc Insider Trading

  • The most recent transaction was 103,200 units sold on December 4, 2020 by Orbimed Israel GP Ltd and Partnership Limited GP Biofund Israel Orbimed worth over $2.23M
  • In the last 3 years, insiders at Novus Therapeutics, Inc sold an estimated value of $2.63M and bought an estimated value of $7.31M
  • The most active traders are Catherine C Turkel, President,  Gregory J Flesher, Chief Executive Officer,  and Jon Kuwahara, See Remarks
  • Insider trading is most common in May, with the busiest year in 2019

Eledon Pharmaceuticals, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1